Dr. Meintjes Visits Japan to Speak on Latest PGS Techniques
By Frisco Institute For Reproductive Medicine
Frisco Institute for Reproductive Medicine lab director spoke at the Japan Society of Assisted Reproduction conference on the latest genetic screening techniques
Frisco, TX (Oct. 7, 2016) – This past weekend, Dr. Marius Meintjes lectured on the latest in the field of preimplantation genetic screening at the 19th annual conference of the Japan Society of Assisted Reproduction (JSAR).
Dr. Meintjes, lab director at Frisco Institute for Reproductive Medicine (FIRM), was invited to be a guest speaker for this event as a globally-recognized authority in the field of assisted reproductive technology (ART) and fertility.
Dr. Marius Meintjes with colleagues at the Japan Society of Assisted Reproduction conference
The theme of the JSAR conference – co-sponsored by Vitrolife and held Oct. 1-2, 2016 – centered on “The next generation of ART.” Presentations emphasized breakthrough research in genetic testing, stem cell treatments, time-lapse imaging of cell development and more to promote further progress in the field of ART.
While in Japan, Dr. Meintjes also delivered a guest lecture on similar topics at the University of Tokyo.
FIRM’s cutting-edge infertility lab is one of the few in the United States to offer time-lapse-assisted embryo selection utilizing computer-controlled microscopes and the special EmbryoScope incubator in which a computer takes an embryo picture every five minutes or less for the six days of embryo culture. Dr. Meintjes was instrumental in implementing the system and shared his expertise with Japanese colleagues.
About Frisco Institute for Reproductive Medicine
High pregnancy success rates rely on advanced technologies in IVF, ICSI and PGD. Our world-class IVF laboratory and reproductive surgery center at Frisco Institute for Reproductive Medicine provide patients with any diagnosis the best opportunity to start a family. We serve Plano, Frisco, McKinney, Allen and the Dallas-Fort Worth area. We believe that to be leaders in Texas IVF, infertility treatments should be no more complex or expensive than necessary for a reasonable likelihood of success.